The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 31, 2018

Filed:

Nov. 25, 2014
Applicant:

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Richard S. Blumberg, Waltham, MA (US);

Kristi Baker, Brookline, MA (US);

Timo Rath, Cambridge, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); C07K 16/28 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); C07K 16/24 (2006.01); C07K 16/00 (2006.01); C12N 15/113 (2010.01); G01N 33/564 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/283 (2013.01); A61K 39/0011 (2013.01); C07K 16/00 (2013.01); C07K 16/244 (2013.01); C12N 15/1138 (2013.01); G01N 33/564 (2013.01); G01N 33/574 (2013.01); G01N 33/6854 (2013.01); G01N 33/6863 (2013.01); G01N 33/6866 (2013.01); G01N 33/6869 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/72 (2013.01); C07K 2317/76 (2013.01); C12N 2310/14 (2013.01); G01N 2333/525 (2013.01); G01N 2333/5434 (2013.01); G01N 2333/57 (2013.01); G01N 2800/52 (2013.01);
Abstract

Described herein are compositions for increasing IL-12 production comprising IgG or a fragment thereof or a variant thereof and uses of said compositions for treating cancer and infectious diseases. Also described herein are compositions for decreasing IL-12 production comprising an agent that inhibits signaling mediated by interaction between FcRn and IgG and uses of said compositions for treating autoimmune diseases. Further described herein are methods for assessing efficacy of treatment by monitoring levels of various cytokines in the subject.


Find Patent Forward Citations

Loading…